LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions. - Yu K; Davidson CL; Wójtowicz A; Lisboa L; Wang T; Airo AM; Villard J; Buratto J; Sandalova T; Achour A; Humar A; Boggian K; et al. (The Journal of clinical investigation, 2018)